Tissue marking
SOMATEX® Medical Technologies
A Hologic Company
At SOMATEX, we design high quality medical products to facilitate diagnoses and therapies. That is how we contribute to making everyday life easier in the medical sector – for users and patients.
Our products
Our products
A Hologic Company
Since January 2021 SOMATEX is part of Hologic. Hologic Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.
Over decades we have become experts in breast tumor localization and set new standards. We are taking the next steps in the fight against breast cancer together with Hologic. With bundled expertise along the path of diagnosis and preparation for surgery, we can provide our users with even more comprehensive support in their everyday clinical work.
Joerg Heise, Managing Director
Our news
30.8.2021
SOMATEX® online at Master of Diaster 2021 on-site and online
News
…
11.6.2021
SOMATEX® online at the Senology Congress 2021
News
…
12.4.2021
SOMATEX® participates in the NCoBC
News
…
14.1.2021
Tumark® Vision: Highest detection rate in SenTa-Study
News
…
5.1.2021
SOMATEX® is now part of Hologic!
News
…
15.12.2020
Product Manager (m/w/d)
Job ad
…
Our products in clinical use
Short video clips show everyday clinical practice in the breast center of the Evang. Kliniken Essen-Mitte in Essen, Germany. In action: our Tumark Vision, Duo System, Somacore Verify and Core Biopsy Needle. Watch these videos about wire marking, breast biopsy and marking of breast lesions here.
Tumark® Vision Atlas
Case studies
The Tumark Vision Atlas contains case studies of the Tumark Vision biopsy site marker and provides clinical information. The long-term visibility of a biopsy site marker is particularly important in neoadjuvant chemotherapy. Some of the following case studies report this application scenario.